COSCIENS Biopharma Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $-2.6M | $-3.3M | $722.0K | $3.9M |
| FY2024 | $-14.6M | $-15.7M | $1.2M | $5.2M |
| FY2025 | $-8.5M | $-9.2M | $706.0K | $6.4M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $-2.6M | $-3.3M | $722.0K | $3.9M |
| FY2024 | $-14.6M | $-15.7M | $1.2M | $5.2M |
| FY2025 | $-8.5M | $-9.2M | $706.0K | $6.4M |